Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02637 HAIXI PHARMA
RT Nominal up113.300 +0.400 (+0.354%)
Cash Flow Statement
Latest  ｜  Final  ｜  Interim
2024/12 - Final
RMB(K¥)		 2023/12
RMB(K¥)		 2022/12
RMB(K¥)
Net Cash from / (used in) Operating Activities163,942147,10685,310
Net Cash from / (used in) Investing Activities(378,716)(12,770)(53,757)
Net Cash from / (used in) Financing Activities(1,268)(51,489)133,129
Increase / (Decrease) in Cash & Cash Equivalents(216,042)82,847164,682
Cash & Cash Equivalents at beginning of period254,324171,4776,795
Effect of Foreign Exchange Rate Changes000
Others000
Cash & Cash Equivalents at end of period38,282254,324171,477
Remarks:  Real time quote last updated: 28/10/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Company Search
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Latest Result
Announcement (2024Year-Final)
More
Profit / (Loss) Attributable to Shareholders (K¥)RMB 136,079
%Change15.857%
EPS / (LPS)RMB 2.020
NBV Per Share (¥)RMB --
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.